CAMPBELL, Calif. & NEW YORK– LiveWorld, Inc. (OTC Markets: LVWD) today announced the appointment of two distinguished pharmaceutical industry leaders, Jennifer Sherak and Helen S. Chang, RPH, to its Board of Directors. Both Jennifer and Helen officially joined the board on January 1, 2024, bringing their wealth of experience and expertise to further guide LiveWorld’s growth in the pharmaceutical sector.
Jennifer Sherak, former SVP & President, Specialty Physician Services at AmerisourceBergen, is an inspirational pharmaceutical commercial executive known for her visionary leadership in company transformation. As the founder of Saige Advisors, LLC, Jennifer provides expert commercial and strategy consultation services for pharmaceutical, biotech, wellness, and skincare industries. With over 25 years of sales and marketing leadership experience, she has successfully led multi-billion-dollar business units, managed product lifecycle planning, and played pivotal roles in major acquisitions within the pharmaceutical industry.
Helen S. Chang, RPh, most recently Vice President, Marketing at Mesoblast Limited, brings a wealth of knowledge in marketing and pharmaceutical/biotech industry to the LiveWorld Board of Directors. With a strong background in brand commercialization, Helen’s expertise lies in driving business strategy, product portfolio expansion, and marketing initiatives. Her dynamic leadership and commitment to growth align seamlessly with LiveWorld’s vision for success in the pharmaceutical sector.
“We are delighted to welcome Jennifer and Helen to the LiveWorld Board of Directors,” said Peter Friedman, Chairman & CEO, LiveWorld, “They are both proven executive leaders in the healthcare and life science industries with business development and marketing expertise. Their guidance and direction will strengthen LiveWorld’s ability to build its client portfolio, relationships, and reputation.”
The newly appointed board members are driven and outcome-oriented commercial leaders, demonstrating proven track records in spearheading patient-centric revenue models and fostering the growth of life science brands through pragmatic execution. With their collective expertise, energy, and extensive industry relationships, they are poised to accelerate LiveWorld’s expansion in the healthcare sector. These additions are anticipated to play a pivotal role in steering LiveWorld’s growth trajectory, particularly as the company broadens its offerings in pharmaceutical client digital agency services and software solutions.
